HEADER AMYLOID PEPTIDE 18-APR-05 2BP4 TITLE ZINC-BINDING DOMAIN OF ALZHEIMER'S DISEASE AMYLOID BETA- TITLE 2 PEPTIDE IN TFE-WATER (80-20) SOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: AMYLOID BETA A4 PROTEIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: 16-MER FRAGMENT BETWEEN THE BETA AND ALPHA COMPND 5 SECRETASES CLEAVAGE SITES OF ALZHEIMER'S DISEASE AMYLOID COMPND 6 A4 PROTEIN, RESIDUES 672-687; COMPND 7 SYNONYM: APP, ABPP, ALZHEIMER'S DISEASE AMYLOID A4 COMPND 8 PROTEIN, CEREBRAL VASCULAR AMYLOID PEPTIDE, CVAP, COMPND 9 PROTEASE NEXIN-II, PN-II, APPI, PREA4 SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 4 ORGANISM_COMMON: HUMAN; SOURCE 5 ORGANISM_TAXID: 9606 KEYWDS 3D-STRUCTURE, HELIX, ALZHEIMER'S DISEASE, AMYLOID, AMYLOID KEYWDS 2 PEPTIDE, BETA-AMYLOID PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR S.ZIRAH,S.A.KOZIN,A.K.MAZUR,A.BLOND,M.CHEMINANT, AUTHOR 2 I.SEGALAS-MILAZZO,P.DEBEY,S.REBUFFAT REVDAT 3 24-FEB-09 2BP4 1 VERSN REVDAT 2 25-JAN-06 2BP4 1 JRNL REVDAT 1 21-APR-05 2BP4 0 SPRSDE 21-APR-05 2BP4 1O6N JRNL AUTH S.ZIRAH,S.A.KOZIN,A.K.MAZUR,A.BLOND,M.CHEMINANT, JRNL AUTH 2 I.SEGALAS-MILAZZO,P.DEBEY,S.REBUFFAT JRNL TITL STRUCTURAL CHANGES OF REGION 1-16 OF THE ALZHEIMER JRNL TITL 2 DISEASE AMYLOID BETA-PEPTIDE UPON ZINC BINDING AND JRNL TITL 3 IN VITRO AGING. JRNL REF J.BIOL.CHEM. V. 281 2151 2006 JRNL REFN ISSN 0021-9258 JRNL PMID 16301322 JRNL DOI 10.1074/JBC.M504454200 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : ICMD REMARK 3 AUTHORS : ALEXEY K. MAZUR REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REFINEMENT DETAILS CAN BE FOUND IN REMARK 3 THE JRNL CITATION ABOVE REMARK 4 REMARK 4 2BP4 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 19-APR-05. REMARK 100 THE PDBE ID CODE IS EBI-23670. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298.0 REMARK 210 PH : 3.0 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : 1.0 REMARK 210 SAMPLE CONTENTS : 80 % TFE-D2OH / 20 % H2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : DQF-COSY, 2D TOCSY REMARK 210 2D NOESY, HSQC, HMBC REMARK 210 SPECTROMETER FIELD STRENGTH : 400 ; 600 REMARK 210 SPECTROMETER MODEL : AVANCE ; DMX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : ICMD 2.7 REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 1000 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : MINIMAL TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: THIS STRUCTURE WAS DETERMINED USING STANDARD 2D REMARK 210 HOMONUCLEAR TECHNIQUES REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 5 GLN A 15 45.11 -91.10 REMARK 500 8 HIS A 14 59.17 -104.97 REMARK 500 11 GLN A 15 45.36 -84.46 REMARK 500 12 GLN A 15 46.35 -87.59 REMARK 500 14 HIS A 14 53.09 -95.48 REMARK 500 17 HIS A 14 60.45 -110.68 REMARK 500 18 HIS A 14 53.24 -101.43 REMARK 500 19 HIS A 14 46.56 -95.78 REMARK 500 20 HIS A 14 -71.08 -92.81 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1AAP RELATED DB: PDB REMARK 900 REMARK 900 RELATED ID: 1AMB RELATED DB: PDB REMARK 900 ALZHEIMER'S DISEASE AMYLOID BETA-PEPTIDE ( REMARK 900 RESIDUES 1 - 28) (NMR, MINIMIZED AVERAGE REMARK 900 STRUCTURE) REMARK 900 RELATED ID: 1AMC RELATED DB: PDB REMARK 900 ALZHEIMER'S DISEASE AMYLOID BETA-PEPTIDE ( REMARK 900 RESIDUES 1 - 28) (NMR, 5 STRUCTURES) REMARK 900 RELATED ID: 1AML RELATED DB: PDB REMARK 900 THE ALZHEIMER`S DISEASE AMYLOID A4 PEPTIDE REMARK 900 (RESIDUES 1-40) REMARK 900 RELATED ID: 1BA4 RELATED DB: PDB REMARK 900 THE SOLUTION STRUCTURE OF AMYLOID BETA- REMARK 900 PEPTIDE (1-40) IN A WATER-MICELLE REMARK 900 ENVIRONMENT. IS THE MEMBRANE-SPANNING DOMAIN REMARK 900 WHERE WE THINK IT IS? NMR, 10 STRUCTURES REMARK 900 RELATED ID: 1BA6 RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE METHIONINE-OXIDIZED REMARK 900 AMYLOID BETA-PEPTIDE (1-40). DOES REMARK 900 OXIDATION AFFECT CONFORMATIONAL SWITCHING? NMR REMARK 900 , 10 STRUCTURES REMARK 900 RELATED ID: 1BJB RELATED DB: PDB REMARK 900 SOLUTION NMR STRUCTURE OF AMYLOID BETA[E16 REMARK 900 ], RESIDUES 1-28, 14 STRUCTURES REMARK 900 RELATED ID: 1BJC RELATED DB: PDB REMARK 900 SOLUTION NMR STRUCTURE OF AMYLOID BETA[F16 REMARK 900 ], RESIDUES 1-28, 15 STRUCTURES REMARK 900 RELATED ID: 1BRC RELATED DB: PDB REMARK 900 REMARK 900 RELATED ID: 1CA0 RELATED DB: PDB REMARK 900 BOVINE CHYMOTRYPSIN COMPLEXED TO APPI REMARK 900 RELATED ID: 1HZ3 RELATED DB: PDB REMARK 900 ALZHEIMER'S DISEASE AMYLOID-BETA PEPTIDE ( REMARK 900 RESIDUES 10-35) REMARK 900 RELATED ID: 1IYT RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE ALZHEIMER'S REMARK 900 DISEASE AMYLOID BETA-PEPTIDE (1-42) REMARK 900 RELATED ID: 1MWP RELATED DB: PDB REMARK 900 N-TERMINAL DOMAIN OF THE AMYLOID PRECURSOR REMARK 900 PROTEIN REMARK 900 RELATED ID: 1O6N RELATED DB: PDB REMARK 900 ABETA(1-16) FRAGMENT OF THE AMYLOID REMARK 900 PEPTIDE REMARK 900 RELATED ID: 1OWT RELATED DB: PDB REMARK 900 STRUCTURE OF THE ALZHEIMER'S DISEASE AMYLOID REMARK 900 PRECURSORPROTEIN COPPER BINDING DOMAIN REMARK 900 RELATED ID: 1QCM RELATED DB: PDB REMARK 900 AMYLOID BETA PEPTIDE (25-35), NMR, 20 REMARK 900 STRUCTURES REMARK 900 RELATED ID: 1QWP RELATED DB: PDB REMARK 900 NMR ANALYSIS OF 25-35 FRAGMENT OF BETA REMARK 900 AMYLOID PEPTIDE REMARK 900 RELATED ID: 1QXC RELATED DB: PDB REMARK 900 NMR STRUCTURE OF THE FRAGMENT 25-35 OF REMARK 900 BETA AMYLOID PEPTIDEIN 20/80 V:V REMARK 900 HEXAFLUOROISOPROPANOL/WATER MIXTURE REMARK 900 RELATED ID: 1QYT RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF FRAGMENT (25-35) OF REMARK 900 BETA AMYLOIDPEPTIDE IN SDS MICELLAR SOLUTION REMARK 900 RELATED ID: 1TAW RELATED DB: PDB REMARK 900 BOVINE TRYPSIN COMPLEXED TO APPI REMARK 900 RELATED ID: 1TKN RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF CAPPD*, AN INDEPENDENTLY REMARK 900 FOLDEDEXTRACELLULAR DOMAIN OF HUMAN AMYLOID- REMARK 900 BETA PRECURSORPROTEIN REMARK 900 RELATED ID: 1UO7 RELATED DB: PDB REMARK 900 MOLECULAR DYNAMICS SIMULATION OF AMYLOID BETA REMARK 900 1-42 (PDB: 1IYT) IN WATER REMARK 900 RELATED ID: 1UO8 RELATED DB: PDB REMARK 900 AFTER 2NS REMARK 900 RELATED ID: 1UOA RELATED DB: PDB REMARK 900 AFTER 3NS REMARK 900 RELATED ID: 1UOI RELATED DB: PDB REMARK 900 AFTER 4NS REMARK 900 RELATED ID: 2BOM RELATED DB: PDB REMARK 900 MODEL OF ALZHEIMER'S DISEASE AMYLOID-SS REMARK 900 PEPTIDE BASED ON A RNA BINDING PROTEIN REMARK 999 REMARK 999 SEQUENCE REMARK 999 PEPTIDE FRAGMENT 672-687 DBREF 2BP4 A 1 16 UNP P05067 A4_HUMAN 672 687 SEQRES 1 A 16 ASP ALA GLU PHE ARG HIS ASP SER GLY TYR GLU VAL HIS SEQRES 2 A 16 HIS GLN LYS HELIX 1 1 ASP A 1 GLN A 15 1 15 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1